Visit
International Workshop on non-Hodgkin Lymphoma (iwNHL), 6-8 May 2021
VJHemOnc is pleased to be the official media partner for iwNHL 2021, an event encouraging interactive debates and discussions on non-Hodgkin lymphoma (NHL) and related disorders in a workshop environment.
This workshop will highlight efforts to understand the biology of different NHL subtypes to further refine therapeutic strategies. Some of the world’s leading clinical researchers in NHL will share their perspectives on how to place this evolving understanding in a clinical context and thereby optimize clinical care.
This event is for hematologists, researchers, nurses, and allied medical professionals only. Please apply for registration by filling in the form and confirming your details. We will review your application and confirm your registration on submission.
By applying, you confirm that your details are correct and that the organizer can communicate with you regarding this event.
Thursday: May 6, 2021
10:00 (EST)
Day 1: Introduction & Virtual Meeting Objectives
John Gribben
10:10 -11:30
Session I: T-Cell Lymphoma
Chairs: Laurence de Leval & Francine Foss
- EBV-associated lymphoproliferations:
- Pathobiology and Spectrum; Elaine Jaffe
- Clinical Perspective; Arnaud Jaccard
- Biology clinics and management of breast implant-associated ALCLs
- experience from the French registry; Corinne Haioun
- Update and perspectives for epigenetic modifier therapy in PTCLs; Lorenzo Falchi
Roundtable discussion
11:30 – 1:00
Session II: Immunotherapy/Microenvironment
Chairs: David Maloney & Stephen Ansell
- Targeting the Immune Microenvironment; Massimo Di Nicola
- Crosstalk between lymphocytes and their microenvironment; Patricia Pérez Galán
- CBT in specific lymphoma subtypes; Stephen Ansell
- ROR1 CARs and the tumour microenvironment; Stan Riddell
- IMIDS in combination; Alexandra Albertsson-Lindblad
- Checkpoint Inhibitors; Scott J. Rodig
Roundtable discussion
1:00
End Day 1: Roundup of Day 1:
John Gribben, David Maloney, Laurence De Leval, Stephen Ansell, Francine Foss
Friday: May 7, 2021
10:00 – 10:10
Day 2: Introduction
John Gribben
10:10 – 11:20
Session III: Mantle Cell Lymphoma
Chair: Elaine Jaffe
- Introduction; Elaine Jaffe
- Keynote Speaker; Elias Campo
Roundtable Discussion
11:20 – 1:15
Session IV: Novel Therapies Part I
Chairs: Laurie Sehn & Franck Morschhauser
- ADCs:
- Polatuzumab vedotin; Laurie Sehn
- Loncastuximab Tesirine; Brad Kahl
- ADCT–301 camidanlumab tesirine; Graham Collins
- CD20/CD3 bispecific antibodies: How to choose?
- Mosunetuzumab; Stephen J. Schuster
- CD20 TCB; Franck Morschhauser
- REGN1979; Rajat Bannerji
- DuoBody-CD3xCD20 (Epcoritamab); Tuna Mutis
- Oral PI3K delta (δ) inhibitors in lymphoma; Jennifer Brown
Roundtable Discussion
1:15
End Day 2: Roundup of Day 2:
John Gribben, Laurie Sehn, Franck Morschhauser, Elias Campo
Saturday: May 8, 2021
10:00 – 10:10
Day 3: Introduction
John Gribben
10:10 – 12:00
Session V: Novel Therapies Part II
Chairs: Gilles Salles & Sonali Smith
- Novel BTK inhibitors: how to choose?
- Ibrutinib combinations; Paolo Ghia
- Zanubrutinib; Michael Wang
- Acalabrutinib; Tom Witzig
- Loxo-305; Anthony Mato
- Tirabrutinib; Alexey Danilov
- SINE inhibitors: Selinexor; Sundar Jagannath
- Tafasitamab (MOR208) in DLBCL; Gilles Salles
Roundtable Discussion
12:00 – 1:45
Session VI: T-cell Therapies for Lymphoma
Chairs: Cath Bollard & Jeremy Abramson
- CD19-CAR- T cells:
- Lisocabtagene maraleucel (liso-cel) in DLBCL; Jeremy Abramson
- Axicabtagene ciloleucel (axi-cel) in DLBCL; Sattva S. Neelapu
- Tisagenlecleucel in DLBCL; Stephen Schuster
- CD30-CAR T cells; Barbara Savoldo
- CD5 and/or 7 CAR T cells; Max Mamomkin
- Antigen-specific T cell Overview; Cath Bollard
- Third party EBV T cells; Susan Prockop
Roundtable Discussion
1:45
End Day 3: Virtual Meeting Summary & Conclusions
iwNHL Scientific Committee
This event is for hematologists, researchers, nurses, and allied medical professionals only. Please apply for registration by filling in the form and confirming your details. We will review your application and confirm your registration on submission. By applying, you confirm that your details are correct and that the organizer can communicate with you regarding this event.
VJHemOnc is intended for Healthcare Professionals onlyBy choosing to continue, you are confirming that you are a healthcare professional
Sign-up for our Newsletter!
Keep up to date with all the latest news with our monthly newsletter
